BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8176105)

  • 1. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.
    de Simone G; Devereux RB; Roman MJ; Ganau A; Saba PS; Alderman MH; Laragh JH
    J Am Coll Cardiol; 1994 May; 23(6):1444-51. PubMed ID: 8176105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of obesity on left ventricular midwall mechanics in arterial hypertension.
    de Simone G; Devereux RB; Mureddu GF; Roman MJ; Ganau A; Alderman MH; Contaldo F; Laragh JH
    Hypertension; 1996 Aug; 28(2):276-83. PubMed ID: 8707394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in left ventricular chamber and midwall systolic function in normotensive and hypertensive adults.
    Celentano A; Palmieri V; Arezzi E; Mureddu GF; Sabatella M; Di Minno G; De Simone G
    J Hypertens; 2003 Jul; 21(7):1415-23. PubMed ID: 12817192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic function in hypertensive men with concentric remodeling.
    Sadler DB; Aurigemma GP; Williams DW; Reda DJ; Materson BJ; Gottdiener JS
    Hypertension; 1997 Oct; 30(4):777-81. PubMed ID: 9336372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations of longitudinal left ventricular systolic function to left ventricular mass, load, and Doppler stroke volume.
    Palmieri V; Russo C; Arezzi E; Pezzullo S; Sabatella M; Minichiello S; Celentano A
    Eur J Echocardiogr; 2006 Oct; 7(5):348-55. PubMed ID: 16140588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
    Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
    Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension.
    de Simone G; Devereux RB; Koren MJ; Mensah GA; Casale PN; Laragh JH
    Circulation; 1996 Jan; 93(2):259-65. PubMed ID: 8548897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocardial versus midwall measurement of left ventricular function in mild hypertension: an insight from the Harvest Study.
    Palatini P; Visentin P; Nicolosi G; Mione V; Stritoni P; Michieletto M; Graniero G; Mormino P; Pessina AC
    J Hypertens; 1996 Aug; 14(8):1011-7. PubMed ID: 8884557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related variations of left ventricular endocardial and midwall function in healthy infants, children, and adolescents.
    Crepaz R; Cemin R; Pedron C; Gentili L; Trevisan D; Pitscheider W
    Ital Heart J; 2005 Aug; 6(8):634-9. PubMed ID: 16161496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonic myocardial textural parameters and midwall left ventricular mechanics in essential arterial hypertension.
    Di Bello V; Pedrinelli R; Giorgi D; Bertini A; Talini E; Dell'Omo G; Paterni M; Giusti C
    J Hum Hypertens; 2000 Jan; 14(1):9-16. PubMed ID: 10673725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midwall LV mechanics in rats with or without renovascular hypertension: effect of different Na+ intakes.
    De Simone G; Devereux RB; Volpe M; Camargo MJ; Wallerson DC; Laragh JH
    Am J Physiol; 1996 Feb; 270(2 Pt 2):H628-37. PubMed ID: 8779839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of regression of left ventricular hypertrophy from systemic hypertension on systolic function assessed by midwall shortening (HOT echocardiographic study).
    Zabalgoitia M; Rahman SN; Haley WE; Yarows S; Krause L; Anderson LC; Oraby MA; Amarena J
    Am J Cardiol; 2001 Sep; 88(5):521-5. PubMed ID: 11524061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy.
    Aurigemma GP; Silver KH; Priest MA; Gaasch WH
    J Am Coll Cardiol; 1995 Jul; 26(1):195-202. PubMed ID: 7797752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure.
    Schillaci G; Verdecchia P; Reboldi G; Pede S; Porcellati C
    Am J Cardiol; 2000 Sep; 86(5):509-13. PubMed ID: 11009267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of left ventricular systolic function using midwall mechanics in patients >60 years of age with hypertensive heart disease and heart failure.
    Vinch CS; Aurigemma GP; Simon HU; Hill JC; Tighe DA; Meyer TE
    Am J Cardiol; 2005 Nov; 96(9):1299-303. PubMed ID: 16253602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between left ventricular geometric patterns and left ventricular midwall mechanics in hypertensive patients.
    Jiang Y; Qu P; Ding Y; Xia D; Wang H; Tian X
    Hypertens Res; 2002 Mar; 25(2):191-5. PubMed ID: 12047034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mass and systolic dysfunction in essential hypertension.
    Schillaci G; Vaudo G; Pasqualini L; Reboldi G; Porcellati C; Verdecchia P
    J Hum Hypertens; 2002 Feb; 16(2):117-22. PubMed ID: 11850769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of left ventricular longitudinal and circumferential shortening to ejection fraction in the presence or in the absence of mild hypertension.
    de Simone G; Ganau A; Roman MJ; Devereux RB
    J Hypertens; 1997 Sep; 15(9):1011-7. PubMed ID: 9321749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular midwall mechanics in subjects with aortic stenosis and normal systolic chamber function.
    Ballo P; Mondillo S; Motto A; Faraguti SA
    J Heart Valve Dis; 2006 Sep; 15(5):639-50. PubMed ID: 17044369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study.
    Wachtell K; Gerdts E; Palmieri V; Olsen MH; Nieminen MS; Papademetriou V; Boman K; Dahlöf B; Aurigemma GP; Rokkedal JE; Devereux RB
    J Hypertens; 2010 Jul; 28(7):1541-6. PubMed ID: 20410835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.